Ocata Therapeutics Inc fka OCAT

[crawford2012]

Read the past 20 posts and I felt like saying something.
What should we expect tomorrow?
We should look at this from two angles (never one, as none of us have a crystal ball or sit in on the board meeting when they are in session).
First Angle:
- The company has been progressing
- The company has been adding man power (not any man power); they are heavy weights with connections.
- The company has been clear, honest and transparent
- The Clinical trials have been successful (knock on wood), and we are continuing with next.
- The Company wants to move out of the pink to the big board.
IMHO - only a company that is going somewhere will consider doing so. And I hope I am not naive enough to think that ACT is just doing it for fun. G.Rabin has previous experience in the field and this is why he is steering the ship in the right direction.
- The company has many patents.
- The company is anxiously working hard to get the cure to blindness on the market.
So much is happening in the right direction.

Now the 2nd Angle.
If the company has not done any of the above then we should be concerned, also if the clinical trials have failed. We would still be at ground level zero.

IMHO - I feel this retraction is like someone pulling a sling shot and they are about to release it.
In every business there are issues and hurdles to go over in order to move to next.

I hope the meeting is very fruitful and I wish all of you the best.
Cheers!